Company profile · Sponsor
Cosmo
Cosmo Technologies Ltd
- Pipeline
- 3
- Drugs
- 0
- Patents
- 0
Quick answer
Cosmo (E28E90F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (3)
Search pipeline →-
Monofer
Cosmo
Chronic Kidney Disease Stage 5 (Dialysis Dependent)
1 trial -
Colesevelam hydrochloride-MMX® modified-release placebo tablets, Colesevelam hydrochloride-MMX® 900 mg modified-release tablets
Cosmo
bile acid diarrhoea (BAD)
1 trial -
Rifamycin SV sodium in situ gelling solution matching placebo (80 mL) for rectal administration, Rifamycin 1% in situ gelling solution (80 mL) for rectal administration
Cosmo
patients with mild to moderate left-sided ulcerative colitis
1 trial
Frequently asked questions
What is Cosmo?
Cosmo (E28E90F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does Cosmo sponsor?
We track 3 ClinicalTrials.gov-linked programs for Cosmo, including Monofer and 2 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Cosmo company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.